We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TENX icon
9726
Tenax Therapeutics
TENX
$503M
$18 ﹤0.01%
3
-685
-100% -$3.32K
UPGR icon
9727
Xtrackers US Green Infrastructure Select Equity ETF
UPGR
$630K
$18 ﹤0.01%
+1
New +$19
AREBW
9728
DELISTED
American Rebel Holdings Warrants
AREBW
$17 ﹤0.01%
+14
New +$15
REK icon
9729
ProShares Short Real Estate
REK
$11.8M
$17 ﹤0.01%
1
BNBX
9730
DELISTED
BNB PLUS CORP
BNBX
0
ATMCW
9731
DELISTED
AlphaTime Acquisition Corp Warrant
ATMCW
$16 ﹤0.01%
+800
New +$15
TOIIW
9732
DELISTED
The Oncology Institute Warrant
TOIIW
$16 ﹤0.01%
3,106
-2,977
-49% -$46
ABLVW icon
9733
Able View Global Warrant
ABLVW
$15 ﹤0.01%
+815
New +$13
COEPW
9734
DELISTED
Coeptis Therapeutics Warrants
COEPW
$15 ﹤0.01%
678
+634
+1,441% +$15
HYMCL
9735
DELISTED
Hycroft Mining Holding Corp Warrants
HYMCL
$15 ﹤0.01%
1,137
-5,062
-82% -$112
KPLTW
9736
DELISTED
Katapult Holdings Warrant
KPLTW
$15 ﹤0.01%
2,510
-1,182
-32% -$8
LPCN icon
9737
Lipocine
LPCN
$17.6M
$15 ﹤0.01%
3
-59,410
-100% -$302K
SXTPW icon
9738
60 Degrees Pharmaceuticals Warrant
SXTPW
$15 ﹤0.01%
506
+426
+533% +$12
INLX icon
9739
Intellinetics
INLX
$14 ﹤0.01%
1
LCFY icon
9740
Locafy
LCFY
$4.28M
$14 ﹤0.01%
+2
New +$13
MCHX icon
9741
Marchex
MCHX
$79.7M
$14 ﹤0.01%
+8
New +$15
FTIIW
9742
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$14 ﹤0.01%
+921
New +$21
FCUV icon
9743
Focus Universal
FCUV
$3.65M
-572
Closed -$58.4K
HFBL icon
9744
Home Federal Bancorp
HFBL
$71.5M
$13 ﹤0.01%
1
-302
-100% -$3.77K
PSFE.WS
9745
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$13 ﹤0.01%
+500
New +$14
CYTHW
9746
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$13 ﹤0.01%
+175
New +$28
HYZNW
9747
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$13 ﹤0.01%
2,651
+2,630
+12,524% +$45
FMY
9748
First Trust Mortgage Income Fund
FMY
$48.7M
$12 ﹤0.01%
1
-750
-100% -$9.08K
PYPD icon
9749
PolyPid
PYPD
$92.8M
$12 ﹤0.01%
4
-1,988
-100% -$6.54K
RBOT.WS
9750
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$12 ﹤0.01%
+474
New +$17

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.